ghrelin and glp-1 inversely regulate insulin secretion and action in pancreatic islets, vagal afferents, and hypothalamus for controlling glycemia and feeding | American Journal of Physiology-Cell Physiology Ghrelin, the proglucagon-derived peptides and

Experience the benefits of advanced GLP-1 therapy tailored just for you

Key timing considerations: Side effect profile tends to be somewhat milder than semaglutide, which may reduce the importance of sleep-through timing Same 48-hour minimum spacing rule applies if changing injection days Pre-filled pen format means no reconstitution time, making spontaneous timing adjustments easier Many dulaglutide users report minimal side effects after the first month, at which point timing becomes purely a convenience decision Retatrutide (weekly injectable, investigational) Dosing frequency: Once weekly Half-life: Data from Phase 2 trials suggest approximately 6 days Peak concentration: Approximately 24 to 72 hours after injection Recommended timing approach: As a triple agonist (GLP-1/GIP/glucagon), retatrutide may produce a different side effect profile than pure GLP-1 or dual GLP-1/GIP agonists

However, a 57% reduction in renal events was observed compared to those receiving only GLP-1 RAs (114)

If you would like to know more about these options, call us today to schedule your free consultation and start losing weight today!

GLP-1s are widely recognized for their role in weight loss and lowering blood sugar